Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 10.57 is 118% above its 5-year average of 4.84, near the high end of its 5-year range (0.00–15.03).
As of the fiscal period ended Tuesday, June 30, 2026. 76.92% above its 12-month average of 5.98.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 10.57.
CURRENT RATIO
10.57
CURRENT RATIO AVG TTM
5.98
CURRENT RATIO AVG 3Y
7.51
CURRENT RATIO AVG 5Y
4.84
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+76.92%
CURRENT VS 3Y AVG
+40.74%
CURRENT VS 5Y AVG
+118.31%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+181.19%
vs the sector median at left
Bullfrog AI Holdings, Inc. Common Stock
Market Cap
$12.78M
Current Ratio
10.57
TTM Avg
5.98
3Y Avg
7.51
5Y Avg
4.84
Market Cap
$12.58M
Current Ratio
0.38
TTM Avg
2.35
3Y Avg
3.38
5Y Avg
3.85
Market Cap
$12.44M
Current Ratio
0.66
TTM Avg
2.17
3Y Avg
2.40
5Y Avg
3.73
Market Cap
$13.20M
Current Ratio
0.84
TTM Avg
0.51
3Y Avg
4.20
5Y Avg
6.42
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $12.78M | 10.57 | 5.98 | 7.51 | 4.84 |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.58M | 0.38 | 2.35 | 3.38 | 3.85 |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | 0.99 | 0.99 | 1.05 | 1.43 |
| Cytosorbents Corporation (CTSO)vs › | $12.44M | 0.66 | 2.17 | 2.40 | 3.73 |
| Passage Bio, Inc. (PASG)vs › | $13.11M | 1.22 | 3.07 | 6.03 | 8.35 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.20M | 0.84 | 0.51 | 4.20 | 6.42 |
| Optimi Health Corp. (OPTH)vs › | $13.30M | 1.73 | 0.30 | 1.36 | 3.00 |
| IN8bio, Inc. (INAB)vs › | $13.33M | 8.21 | 6.45 | 5.32 | 7.60 |
| Lantern Pharma Inc. (LTRN)vs › | $12.17M | 1.96 | 4.12 | 11.35 | 18.88 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.06M | 6.66 | 2.77 | 1.93 | 5.53 |
Current Ratio
10.57
Quick Ratio
10.57
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 10.57 |
| 2026-03-31 | 8.15 |
| 2025-12-31 | 3.85 |
| 2025-09-30 | 3.34 |
| 2025-06-30 | 3.97 |
| 2025-03-31 | 4.86 |
| 2024-12-31 | 9.43 |
| 2024-09-30 | 5.90 |
| 2024-06-30 | 8.78 |
| 2024-03-31 | 9.05 |
| 2023-12-31 | 15.03 |
| 2023-09-30 | 9.43 |
| 2023-06-30 | 5.29 |
| 2023-03-31 | 3.87 |
| 2022-12-31 | 0.02 |
| 2022-09-30 | 0.02 |
| 2022-06-30 | 0.12 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 0.01 |
| 2021-09-30 | 0.00 |
| 2021-06-30 | 0.00 |
